STAAB THOMAS R II

SEC source: 0001193125-26-392319 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,675

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.90 to $1.95. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001193125-26-221926 · ownership.xml · derivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2036-05-11

F2 · derivative.exercise_date: The options vest and become exercisable as follows: 25% vest on May 11, 2027, and thereafter, the remainder vest in substantially equal installments on each monthly anniversary of the grant date for a period of 36 months, subject to the Reporting Person's continued employment.

SEC source: 0001193125-26-221926 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: Represents a restricted stock award which vests 25% ten days after the grant date, with the remainder vesting in three equal installments on the four-month, eight-month and twelve-month anniversaries of the grant date, subject to the Reporting Person's continued employment.

SEC source: 0001193125-26-214913 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,609

F1 · shares: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units.

SEC source: 0001193125-26-116117 · ownership.xml · derivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,295

Underlying: Common Stock · 5,500 shares

Expires 2033-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 25% of the award on January 11, 2024 and vests, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001193125-26-116117 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,959

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-061464 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,459

F1 · shares: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units.

SEC source: 0001193125-26-011796 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,535

F1 · shares: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units.

SEC source: 0000950170-25-024336 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,361

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000950170-25-015541 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,595

F1 · shares: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").

SEC source: 0000950170-24-095487 · ownership.xml · derivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,795

Underlying: Common Stock · 3,500 shares

Expires 2033-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 25% of the award on January 11, 2024 and vests, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000950170-24-095487 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,434

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-055774 · ownership.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,934

F2 · shares: Consists of RSUs. Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000950170-24-055774 · ownership.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,934

F1 · shares: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").

SEC source: 0000899243-23-001798 · doc4.xml · derivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,295

Underlying: Common Stock · 23,295 shares

Expires 2033-01-11

F2 · derivative.exercise_date: The option vests as to 25% of the award on January 11, 2024 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-23-001798 · doc4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,787

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-22-037965 · doc4.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,131

F3 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.15 to $3.17. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-037965 · doc4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,404

F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.15 to $3.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes (i) 970 shares acquired under the Issuer's Employee Stock Purchase Plan since January 13, 2022, the date of the last Form 4 filed by the Reporting Person (the "Reference Date"), and (ii) 19,276 shares that were previously awarded as restricted stock on July 22, 2020 (subject to an amendment of such award on December 7, 2020) and that vested between the Reference Date and the date hereof. Such restricted stock award was reported in the Reporting Person's Form 3 filed on September 17, 2020, and additional restricted stock awarded pursuant to the related amendment was reported in the Reporting Person's Form 4 filed on December 10, 2020.

SEC source: 0000899243-22-001924 · doc4.xml · derivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires 2032-01-11

F2 · derivative.exercise_date: The option vests as to 25% of the award on January 11, 2023 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-22-001924 · doc4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,409

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-21-015711 · doc4.xml · derivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,197

Underlying: Common Stock · 49,197 shares

Expires 2031-04-12

F1 · derivative.exercise_date: The option vests as to 25% of the award on April 12, 2022 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-20-033396 · doc4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,657

F1 · shares: Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the "Original Award"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date.

SEC source: 0001127602-20-007625 · form4.xml · derivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2024-12-22

F1 · date: On February 21, 2020, the company received payment for 20,000 doses of RAPIVAB? (peramivir injection) delivered to the U.S. Department of Health and Human Services under the company's procurement contract. As a result, one of the vesting criteria associated with the performance-based stock options awarded to all employees in December 2014, excluding the Chief Executive Officer, has been met. Therefore, 20% of the performance-based stock options vested.

SEC source: 0001127602-20-006488 · form4.xml · derivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,500

Underlying: Common Stock · 31,500 shares

Expires 2024-12-22

F1 · date: On February 18, 2019, BioCryst Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted and filed its new drug application for the approval of oral, once daily berotralstat (BCX7353) for the prevention of hereditary angioedema attacks. As a result, one of the vesting criteria associated with the performance-based stock options awarded to all employees in December 2014, excluding the Chief Executive Officer, has been met. Therefore, 35% of the performance-based stock options vested.

SEC source: 0001127602-19-035544 · form4.xml · derivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,000

Underlying: Common Stock · 165,000 shares

Expires 2029-12-17

F1 · shares: Annual Employee option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-19-035849 · form4a.xml · derivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,000

Underlying: Common Stock · 127,000 shares

Expires 2029-12-17

F1 · shares: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-19-019143 · form4.xml · nonDerivative · entry 3

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,176

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.41 to $7.45. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-019143 · form4.xml · derivative · entry 4

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,000

Underlying: Common Stock · 4,750 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-019143 · form4.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.55 to $8.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-019143 · form4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018740 · form4.xml · derivative · entry 6

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,750

Underlying: Common Stock · 4,750 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 4

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,176

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.71 to $8.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 3

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018740 · form4.xml · derivative · entry 5

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,500

Underlying: Common Stock · 4,500 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.55 to $7.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-018740 · form4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018347 · form4.xml · derivative · entry 6

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,250

Underlying: Common Stock · 9,750 shares

Expires 2027-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 4

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.65 to $7.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 3

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018347 · form4.xml · derivative · entry 5

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,000

Underlying: Common Stock · 9,750 shares

Expires 2027-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.51 to $7.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-018347 · form4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-017457 · form4.xml · derivative · entry 6

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,750

Underlying: Common Stock · 9,000 shares

Expires 2027-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 4

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.43 to $7.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 3

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-017457 · form4.xml · derivative · entry 5

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,750

Underlying: Common Stock · 7,750 shares

Expires 2027-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.19 to $7.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

SEC source: 0001127602-19-017457 · form4.xml · nonDerivative · entry 1

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-014988 · form4.xml · derivative · entry 3

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,500

Underlying: Common Stock · 7,500 shares

Expires 2027-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

SEC source: 0001127602-19-014988 · form4.xml · nonDerivative · entry 2

STAAB THOMAS R II · CIK 0001230708 · Senior Vice President and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,676

F1 · security: The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.

F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.80 to $8.81. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.